Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis
<p dir="ltr">The main aim of this study is to compare the 2 medications denosumab and zoledronic acid for patients with beta-thalassemia major induced osteoporosis. Patients with B-thalassemia major induced osteoporosis will undergo baseline assessment of the bone densitometry by bon...
محفوظ في:
| المؤلف الرئيسي: | Mohamed A. Yassin (16322749) (author) |
|---|---|
| مؤلفون آخرون: | Mohamed O. Abdel Rahman (16555786) (author), Anas A. Hamad (16515247) (author), Abdul Razzakh Poil (16555788) (author), Mohamed T. Abdelrazek (16555791) (author), Radwa M. Hussein (16515249) (author), Nancy A. Kassem (16555795) (author), Afraa M. Fadul (16555796) (author), Sarah A. Elkourashy (16555798) (author), Abdulqadir J. Nashwan (16328993) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study
حسب: Sahar M Nasser (18090838)
منشور في: (2019) -
COVID‐19 and thalassemia beta major in splenectomized patient: Clinical case progression and literature review
حسب: Lina Okar (14777164)
منشور في: (2020) -
Helping patients understand osteoporosis
حسب: Nature Research (16552612)
منشور في: (2016) -
Examining depression, antidepressants use, and class and their potential associations with osteoporosis and fractures in adult women: Results from ten NHANES cohorts
حسب: Rajha, Humam Emad
منشور في: (2025) -
Luspatercept's use in a patient with transfusion‐dependent beta‐thalassemia and intrathoracic extramedullary hematopoiesis (EMH)
حسب: Mohammed Najdat Seijari (17563263)
منشور في: (2024)